ProFound Pharma

ProFound Therapeutics is a biotechnology company launched by Flagship Pioneering that focuses on discovering and developing a new generation of medicines derived from the 'expanded proteome.' The company utilizes its proprietary ProFoundry platform, which combines state-of-the-art protein detection technologies and advanced data science to identify tens of thousands of previously undiscovered proteins encoded by the human genome. By systematically mapping these novel proteins, ProFound aims to uncover new biological pathways and therapeutic targets across a wide range of diseases, including metabolic disorders, oncology, and inflammation. The company's strategy involves developing its own internal pipeline while also seeking strategic partnerships to leverage its vast library of novel protein targets.